| http://www.w3.org/ns/prov#value | - All infections thought by a physician to have been possibly transmitted by this product should be reported by the physician or other healthcare provider to the CSL Behring Pharmacovigilance Department at 1-866-915-6958 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6 ADVERSE REACTIONS Serious adverse reactions identified during postmarketing use were hypersensitivity reactions [see Warnings and
|
